In today’s medicinal industry, the competition for the most regarded, experienced doctors is warming up. This is genuine not just for medicinal service associations; it is also a test for pharmaceutical organizations looking for key opinion leaders (KOLs) to help them in researching, dispatching, and promoting new drugs. KOLs offer significant experiences into disease conditions